180623-75-0

Upstream product

• 108-24-7 acetic anhydride 
• 180623-55-6 1-(4-amino-3-iodobenzyl)-2-trifluoroacetyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 180623-50-1 6,7-Dimethoxy-1-(4-nitrobenzyl)-2-trifluoroacetyl-1,2,3,4-tetrahydroisoquinoline 
• 180623-53-4 1-(4-Aminobenzyl)-6,7-dimethoxy-2-trifluoroacetyl-1,2,3,4-tetrahydroisoquinoline 
• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 10268-39-0 6,7-dimethoxy-1-(4-nitro-benzyl)-3,4-dihydro-isoquinoline 
• 10403-40-4 N-(3,4-dimethoxyphenethyl)-4-nitrophenylacetamide 
• 104-03-0 4-nitrobenzeneacetic acid 
• 10268-26-5 1,2,3,4-tetrahydro-6,7-dimethoxy-1-[(4-nitrophenyl)methyl]isoquinoline 

Downstream Products

• 180623-76-1 1-(4-Acetamido-3-iodobenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 

Relevant academic research and scientific papers

Beta3-Adrenoreceptor agonists, agonist compositions and methods of using

The invention provides β3-adrenoreceptor agonists, pharmaceutical compositions comprising β3-adrenoreceptor agonist compounds, and methods of using such compounds for stimulating, regulating or modulating metabolism of fats in adipos

Iodinated analogs of trimetoquinol as highly potent and selective β2- adrenoceptor ligands

A series of trimetoquinol (1, TMQ) analogs were designed and synthesized based on the lead compound 2, a diiodinated analog of trimetoquinol which exhibits improved selectivity for β2-versus β1-adrenoceptors (AR). To determine the in